The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Share News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.19
Bid: 0.17
Ask: 0.21
Change: 0.00 (0.00%)
Spread: 0.04 (23.529%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.19
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Marlowe executes strategy with whirl of acquisitions

Tue, 02nd Mar 2021 17:12

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Marlowe PLC - London-based safety & compliance services - Acquires HR software business YouManage for GBP1.3 million. Acquires law compliance specialists ESP, ESP Law, and ESP Safeguard for GBP3.2 million. Acquires HR compliance specialist HR Services Partnership for GBP700,000. "These acquisitions are consistent with the three-year strategy recently announced at Marlowe's capital markets day to deepen and broaden our presence in core markets from selective acquisitions," says Marlowe Chief Executive Alex Dacre.

----------

Pantheon Resources PLC - oil & gas exploration company focused on Alaska - Announces the drilling of a new sidetrack into Kuparuk formation at Talitha A well in Alaska after encountering a problem with swelling. "As far as problems go, it's a good problem to have because it was driven by the preliminary data being better than expected at this location and warrants the opportunity to be tested rigorously," says Chief Executive Jay Cheatham.

----------

Nuformix PLC - pharmaceutical development firm based in London - Reports positive results for NXP002, an inhaled tranilast used to treat idiopathic pulmonary fibrosis. Says the study, performed by Newcastle Fibrosis Research Group, examined both the anti-fibrotic and anti-inflammatory potential of NXP002 in combination with the current standard of care, or SOC, therapies. Says the preliminary data from this study shows that the combination of NXP002 with SOC provided strong evidence of additional effects compared to either SOC alone on both fibrotic and inflammatory markers.

----------

Altus Strategies PLC - Africa-focused mining royalty company - Finds broad and high-grade intersections at Tabakorole gold project in Mali. "These are very encouraging drilling results from the Tabakorole gold project in southern Mali. Tabakorole hosts a significant gold resource, which is open along strike in both directions as well as at depth," says Chief Executive Steven Poulton. Says the holes are expected to improve the modelled mineralised grades and widths in a portion of the orebody.

----------

Mycelx Technologies Corp - clean water firm based in Minnesota - Says it has made a strong start to the year with two project extensions signed with customers in Saudi Arabia. "These projects confirm that Mycelx's superior solutions continue to support its customers' efforts to optimise production, increase cost savings and improve energy efficiency," says Mycelx. Expects to commence delivery of the equipment for its third sale to Nigeria in the first quarter of 2020.

----------

Alba Mineral Resources PLC - mineral exploration and development company with assets in Greenland and the UK - Says the physical attributes of the veins intersected at Clogau in Wales reflect the characteristics of the veins that were successfully mined in the past. Says this means that it "could well be a significant contributor to future production", adding that it is necessary to await the results of the drill core assays before reaching any preliminary conclusions.

----------

MGC Pharmaceuticals Ltd - Europe-based biopharmaceutical company - Says Swiss PharmaCan AG increases initial purchase order volume by 85% for first Artemic Rescue production batch, bringing the initial purchase order value to in excess of USD425,000 wholesale revenue to MGC. The initial agreement included a minimum wholesale order quantity of 40,000 units of per quarter. ArtemiC is a clinically tested food supplement containing four natural based ingredients consisting of artemisinin, curcumin, boswellia serrata, and vitamin C.

----------

PetroNeft Resources PLC - Russia-focused oil & gas exploration and production company - Says the hydraulic fracture stimulation program of wells on both the Sibkrayevskoye and the Lineynoye fields successfully completed. Initial results from the wells are "very encouraging". Says the aim of fracking the well was not only to increase production, but also to provide crucial information which can lead to an improved understanding of the optimum forward development plan for the field.

----------

Safestay PLC - hostels operator based in London - Announces sale of 96-bed hostel Barcelona Sea to Beds & Foods Barcelona for EUR900,000. The annual earnings before interest, tax, depreciation and amortisation of the hostel pre Covid-19 was EUR70,000. Says the proceeds will got to paying off the debt for the purchase of another hostel in Barcelona in 2018.

----------

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Oct 2019 12:27

Nuformix Confirms Japan, Asia Licencing Talks As Shares Surge

Nuformix Confirms Japan, Asia Licencing Talks As Shares Surge

Read more
10 Sep 2019 13:47

Nuformix Chief Financial Officer Kirk Siderman-Wolter Resigns Abruptly

(Alliance News) - Pharmaceutical company Nuformix PLC on Tuesday said Chief Financial Officer and Senior Independent Non-Executive Director Kirk Siderman-Wolter has resigned with immediate company

Read more
9 Sep 2019 11:25

Nuformix, Ebers Tech File Patent For Cannabinoid Cocrystals

(Alliance News) - Pharmaceutical company Nuformix PLC on Monday said it and partner Ebers Tech Inc have filed the first patent in relation to cannabinoid cocrystals.The patented cannabinoid

Read more
6 Sep 2019 12:17

Nuformix Hires Cambridge Interstitial Lung Disease Unit Lead Clinician

(Alliance News) - Nuformix PLC said on Friday it has appointed Muhunthan Thillai to its scientific advisory board with immediate effect.Thillai is the lead clinician for the Cambridge Lung

Read more
18 Jul 2019 11:16

Nuformix Annual Loss Narrows As Revenue Jumps On NXP001 Progress

(Alliance News) - Nuformix PLC on Thursday said its revenue multiplied in its most recently-ended financial year as it has secured its first licensing income from NXP001.NXP001 is one of in

Read more
30 May 2019 10:33

WINNERS & LOSERS SUMMARY: De La Rue Down As CEO Exits And Profit Falls

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - LOSERS----------National a

Read more
30 May 2019 10:14

Nuformix Shares Jump On Positive NXP001 Clinical Study Results

LONDON (Alliance News) - Shares in Nuformix PLC surged on Thursday as the company reported positive results in its clinical study of NXP001.Nuformix shares were trading 30% higher at 13.50

Read more
9 Apr 2019 11:25

Nuformix inks cannabinoid therapeutics deal with Ebers Tech

(Sharecast News) - Pharmaceutical development company Nuformix has inked an agreement for cannabinoid therapeutics development, licensing and commercialisation with Canadian outfit Ebers Tech.

Read more
9 Apr 2019 10:46

WINNERS & LOSERS SUMMARY: 7digital Warns Of Need For Capital Raise

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Anglo up -

Read more
22 Mar 2019 08:50

Nuformix Doses First Patient In NXP001 Anti-Nausea Drug Trial

LONDON (Alliance News) - Nuformix PLC on Friday said it has begun clinical studies for its anti-nausea drug NXP001 and dosed its first patient.Shares in Nuformix were down 4.6% at 2.10 on a

Read more
27 Feb 2019 10:48

MHRA gives go-ahead to Nuformix for human studies

(Sharecast News) - Pharmaceutical development company Nuformix has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to begin human pharmacokinetics studies for its lead asset, NXP001, it announced on Wednesday.

Read more
3 Dec 2018 09:53

Nuformix Reports Positive Results From NXP002 Pre-Clinical Trial

LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC on Monday reported positive results from its completed NXP002 fibrosis programme pre-clinical trial for the treatment of a of

Read more
27 Nov 2018 10:04

Nuformix Expands NXP001 Agreement With Additional Pre-Clinical Study

LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC said on Tuesday it has expanded its current licensing agreement with partner Newsummit Biopharma for the development of cancer

Read more
14 Sep 2018 10:17

Nuformix Rises As NXP001 Passes "Major" Pre-Clinical Milestone

LONDON (Alliance News) - Shares in pharmaceutical firm Nuformix PLC rose Friday it has received a GBP500,000 payment after its NXP001 product reached a pre-clinical milestone.Nuformix was a

Read more
12 Sep 2018 16:00

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 SeptemberBahamas PetroleumFlybe GroupBetter Capital PCCWorldwide 14 UK 17

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.